Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines.

Tekijä Lykkesfeldt, A. E., Briand, P.
Julkaistu 1986

Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells

Tekijä Larsen, S S, Heiberg, I, Lykkesfeldt, A E
Julkaistu 2001

Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7.

Tekijä Lykkesfeldt, A. E., Larsen, J. K., Christensen, I. J., Briand, P.
Julkaistu 1984

Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182(R)-6

Tekijä Jensen, B L, Skouv, J, Lundholt, B K, Lykkesfeldt, A E
Julkaistu 1999

Development and characterization of a tamoxifen-resistant breast carcinoma xenograft

Tekijä Naundorf, H, Becker, M, Lykkesfeldt, A E, Elbe, B, Neumann, C, Büttner, B, Fichtner, I
Julkaistu 2000

Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy

Tekijä Elias, D., Vever, H., Lænkholm, A.-V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., Ditzel, H. J.
Julkaisussa Oncogene (2019)

Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial

Tekijä Ejlertsen, B., Aldridge, J., Nielsen, K. V., Regan, M. M., Henriksen, K. L., Lykkesfeldt, A. E., Müller, S., Gelber, R. D., Price, K. N., Rasmussen, B. B., Viale, G., Mouridsen, H.
Julkaistu 2012